Oncotarget Helps to Curb Cancer

Oncotarget is a medical journal in the United States specializing in oncology aspects and is peer-reviewed weekly. The journal is published by Impact Journals and was established in 2010. Mikhail Blagosklonny and Andrei V. Gudkov are well-known personalities as they are the editors-in-chief of the magazine and read full article.

Mainly oncotarget aims at providing rapid publication of outstanding research. Tumors have become more complicated therefore oncotarget goes to the extent of also publishing papers discussing immunology, pathology, endocrinology, age-related diseases, neuroscience, autophagy and cell death, chromosome and physiology to help everyone.

Moreover, oncotarget has a vast array of objectives to achieve which include removing the bridge between specialties, also to connect different fields of biomedical science and to increase the impact of research via intensive review. Moreover, the journal aims at allowing significant discoveries to be shared rapidly and also at introducing the application of basic and clinical science in treatment. Many successful scientists work with the journal to approve of the many types of research submitted and resume its.

There are rules provided to authors who want to submit their paper. For example, the article should not have been published previously, and also the manuscript file should be Microsoft Office, RTF, OpenDocument or WordPerfect. Moreover, the text should be in Times New Roman, single spaced with a 12point font and do not bold manuscript text. Headings also should not be italicized, and an author should use an automated reference manager to get the appropriate format and articles submitted online should be less than 15 MBs. Until these rules and more provided are followed to the latter is when an article can be reviewed to consider it for the journal.

Most of oncotarget section policies are usually openly accessed, indexed and peered reviewed. Since 2010, Oncotarget has released 370 papers related to oxygen. In 2016, two members of oncotarget, Gregg L. Semenza, and William G. Kaelin Jr. won the Lasker Award for inventing a pathway of sensing oxygen. Oncotarget is well known as a multidisciplinary journal with free access to most people. The journal has contributed significantly to the progress of science by helping the researchers have their work shared out. Authors who have information on oncology and have widely benefited and learn more about Oncotarget.

More Visit: www.scijournal.org/impact-factor-of-ONCOTARGET.shtml

Categories: Doctor, Health